The Scientific Team at Immunomic Therapeutics drives the development and innovation of the UNITE platform by conducting cutting-edge research, designing clinical studies, and analyzing experimental data. This team, comprising leading experts and advisors, works collaboratively to advance the company's immunotherapy solutions from the laboratory to clinical application.
Claire Buchta Rosean
Senior Scientist
Daniel B Zwick
Analytical Scientist II
David A. Reardon
Scientific Advisor
E. Antonio Chiocca
Scientific Advisory Board
John H. Sampson
Scientific Advisory Board
Mark Pardoll
Scientific Advisory Board
Paul Nghiem
Scientific Advisor
Teri Heiland
Chief Scientific Officer
WEI SHEN
Associate Director, Vaccine Di...
Yun-Ting Kao
Scientist II
View all